ArticleGynecologic oncology reports2022

High pre-treatment neutrophil-to-lymphocyte ratio as a prognostic marker for worse survival in patients with recurrent/metastatic cervical cancer treated with immune checkpoint inhibitors.

Corinne A Calo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.